Related Experiment Videos
Gabapentin: a unique anti-epileptic agent.
1Pharmacy Practice, College of Pharmacy & Allied Health Professions, Wayne State University, Detroit, Ml, USA.
Neurological Research
|January 5, 2002
Summary
Gabapentin is an anti-epileptic drug effective for complex partial seizures and neuropathic pain. Its efficacy as an adjunct therapy is noted in adults and children, though monotherapy in children presents challenges.
Area of Science:
- Neurology
- Pharmacology
Background:
- Gabapentin, approved in 1993, is an anti-epileptic drug (AED).
- Its mechanism of action is not fully understood.
- It is used for complex partial seizures (CPS) with or without generalization.
Purpose of the Study:
- To review the efficacy and application of gabapentin.
- To highlight its use in various neurological conditions beyond epilepsy.
Main Methods:
- Review of existing literature on gabapentin's clinical applications.
- Analysis of its efficacy in different patient populations and seizure types.
Main Results:
- Gabapentin is effective as an adjunct AED for CPS in adults and children.
- It shows efficacy in various pain syndromes, especially neuropathic pain.
- Monotherapy is more effective in adults than children, with dosing complicated by behavioral side effects in pediatric patients.
Conclusions:
- Gabapentin has a favorable safety profile with limited drug interactions and cognitive effects compared to traditional AEDs.
- Dosing is individualized based on disease, concomitant medications, and renal function.
- Gabapentin remains a valuable therapeutic option for epilepsy and neuropathic pain.